A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring.
On February 28th,...
Like many market participants, you are probably focused on processing a busy week of quarterly earnings reports from prominent names such as Tesla, Goldman...
Amid a more challenging outlook for large-caps, several experts point to mid-caps as the sweet spot for the year's second half. Today's recommendation is...